{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T04:34:07Z","timestamp":1770698047476,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1016\/s0952-7915(98)80172-6","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T06:32:55Z","timestamp":1027578775000},"page":"330-336","source":"Crossref","is-referenced-by-count":149,"title":["Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling"],"prefix":"10.1016","volume":"10","author":[{"given":"Robert T","family":"Abraham","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0952-7915(98)80172-6_BIB1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","article-title":"Immunopharmacology of rapamycin","volume":"14","author":"Abraham","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB2","first-page":"903","article-title":"Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor","volume":"54","author":"Dilling","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB3","first-page":"1982","article-title":"Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro","volume":"55","author":"Shi","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB4","first-page":"3895","article-title":"Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells","volume":"56","author":"Seufferlein","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB5","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1074\/jbc.270.2.815","article-title":"Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells","volume":"270","author":"Sabers","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB6","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/369756a0","article-title":"A mammalian protein targeted by G1-arresting rapamycin-receptor complex","volume":"369","author":"Brown","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: A mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB8","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","article-title":"RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex","volume":"91","author":"Chiu","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1126\/science.1715094","article-title":"Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast","volume":"253","author":"Heitman","year":"1991","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0092-8674(93)90144-F","article-title":"Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression","volume":"73","author":"Kunz","year":"1993","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB11","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1128\/MCB.13.10.6012","article-title":"Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity","volume":"13","author":"Cafferkey","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB12","first-page":"105","article-title":"TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast","volume":"5","author":"Helliwell","year":"1994","journal-title":"Mol Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB13","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.93.24.13780","article-title":"TOR2 is required for organization of the actin cytoskeleton in yeast","volume":"93","author":"Schmidt","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0092-8674(95)90225-2","article-title":"When is a lipid kinase not a lipid kinase? When it is a protein kinase","volume":"83","author":"Hunter","year":"1995","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.270.5233.50","article-title":"PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints","volume":"270","author":"Keith","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0955-0674(96)80060-3","article-title":"Phosphoinositide kinases","volume":"8","author":"Carpenter","year":"1996","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB17","doi-asserted-by":"crossref","first-page":"R789","DOI":"10.1016\/S0960-9822(06)00406-4","article-title":"Cell-cycle signaling: Atm displays its many talents","volume":"7","author":"Westphal","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB18_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/ng0897-397","article-title":"Atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity","volume":"16","author":"Westphal","year":"1997","journal-title":"Nature Genet"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/377441a0","article-title":"Control of p70 S6 kinase by the kinase activity FRAP in vivo","volume":"377","author":"Brown","year":"1995","journal-title":"Nature"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB20","first-page":"389","article-title":"Ribosomal protein S6 phosphorylation and signal transduction","author":"Jefferies","year":"1996"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB21","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1128\/MCB.16.11.6242","article-title":"The principal rapamycin-sensitive p70s6k phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases","volume":"16","author":"Dennis","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB22_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0960-9822(98)70037-5","article-title":"3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro","volume":"8","author":"Alessi","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB23","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1074\/jbc.272.4.2509","article-title":"Rapamycin dissociates p70s6k activation from DNA synthesis stimulated by bombesin and insulin in Swiss 3T3 cells","volume":"272","author":"Withers","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0968-0004(97)01101-8","article-title":"PHAS\/4E-BPs as regulators of mRNA translation and cell proliferation","volume":"22","author":"Lawrence","year":"1997","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0092-8674(00)80125-7","article-title":"A signaling pathway to translational control","volume":"86","author":"Brown","year":"1996","journal-title":"Cell"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB26","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1432-1033.1996.00747.x","article-title":"Initiation of protein synthesis in eukaryotic cells","volume":"236","author":"Pain","year":"1996","journal-title":"Eur J Biochem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB27","first-page":"245","article-title":"mRNA 5\u2032 Cap-binding protein eIF4E and control of cell growth","author":"Sonenberg","year":"1996"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0959-437X(97)80133-5","article-title":"Translational controls impinging on the 5\u2032-untranslated region and initiation factor proteins","volume":"7","author":"Jackson","year":"1997","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB29","doi-asserted-by":"crossref","first-page":"7358","DOI":"10.1128\/MCB.13.12.7358","article-title":"Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E","volume":"13","author":"Rosenwald","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB30","doi-asserted-by":"crossref","first-page":"21176","DOI":"10.1074\/jbc.270.36.21176","article-title":"Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and post-transcriptional levels","volume":"270","author":"Rosenwald","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB31","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1073\/pnas.93.3.1065","article-title":"Translational initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E","volume":"93","author":"Rousseau","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB32","first-page":"648","article-title":"Translation initiation factors induce DNA synthesis and transform NIH 3T3 cells","volume":"2","author":"Smith","year":"1990","journal-title":"New Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB33","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1101\/gad.6.9.1631","article-title":"Ras mediates translation initiation factor 4E-induced malignant transformation","volume":"6","author":"Lazaris-Karatzas","year":"1992","journal-title":"Genes Dev"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB34","first-page":"2415","article-title":"The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth","volume":"13","author":"Rousseau","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB35","doi-asserted-by":"crossref","first-page":"18531","DOI":"10.1074\/jbc.270.31.18531","article-title":"Control of PHAS-I by insulin in 3T3-L1 adipocytes","volume":"270","author":"Lin","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB36","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.1073\/pnas.92.16.7222","article-title":"cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells","volume":"92","author":"Graves","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB37","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1073\/pnas.93.9.4076","article-title":"4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is dependent of mitogen-activated protein kinase","volume":"93","author":"von Manteuffel","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB38","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1002\/j.1460-2075.1996.tb00911.x","article-title":"Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002","volume":"15","author":"Brunn","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/j.1460-2075.1996.tb00398.x","article-title":"Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation","volume":"15","author":"Beretta","year":"1996","journal-title":"EMBO J"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB40_1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.277.5322.99","article-title":"Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin","volume":"277","author":"Brunn","year":"1997","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB41_1","doi-asserted-by":"crossref","first-page":"32547","DOI":"10.1074\/jbc.272.51.32547","article-title":"The mammalian target of rapamycin phosphorylates sites having a (Ser\/Thr)-Pro motif and is activated by antibodies to a region near its COOH terminus","volume":"272","author":"Brunn","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB42_1","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1074\/jbc.272.15.10240","article-title":"Identification of phosphorylation sites in the translational regulator, PHAS-I, that are controlled by insulin and rapamycin in rat adipocytes","volume":"272","author":"Fadden","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj3160447","article-title":"Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells","volume":"316","author":"Diggle","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB44","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1128\/MCB.16.6.2857","article-title":"Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase","volume":"16","author":"Mendez","year":"1996","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB45","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1126\/science.7701324","article-title":"Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor","volume":"267","author":"Yao","year":"1995","journal-title":"Science"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj3120159","article-title":"Role of phosphatidylinositol 3-OH-kinase activity in the inhibition of apoptosis in haemopoietic cells: phosphatidylinositol 3-OH-kinase inhibitors reveal a difference in signalling between interleukin-3 and granulocyte-macrophage colony stimulating factor","volume":"312","author":"Scheid","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB47","first-page":"343","article-title":"Growth factor-dependent survival of rodent fibroblasts requires phosphatidylinositol 3-kinase but is independent of pp70s6k activity","volume":"13","author":"Yao","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S0952-7915(98)80172-6_BIB48_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.onc.1201234","article-title":"Raf\/MAPK and rapamycin-sensitive pathways mediate the anti-apoptotic function of p21Ras in IL-3-dependent hematopoietic cells","volume":"15","author":"Kinoshita","year":"1997","journal-title":"Oncogene"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791598801726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791598801726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T22:24:32Z","timestamp":1578435872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791598801726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["S0952791598801726"],"URL":"https:\/\/doi.org\/10.1016\/s0952-7915(98)80172-6","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}